Show simple item record

dc.contributor.authorVera-Ponce, V.J.
dc.contributor.authorGuerra, J.V.
dc.contributor.authorTorres-Malca, J.R.
dc.contributor.authorZuzunaga-Montoya, F.E.
dc.contributor.authorLoayza-Castro, J.A.
dc.contributor.authorGuillen, N.R.P.
dc.contributor.authorZenas-Trujillo, G.Z.
dc.contributor.authorValladares-Garrido, M.J.
dc.contributor.authorRamos, W.C.M.
dc.contributor.authorDe La Cruz-Vargas, J.A.
dc.date.accessioned2025-10-31T18:35:46Z
dc.date.available2025-10-31T18:35:46Z
dc.date.issued2023
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5327
dc.description.abstractBackground: The metabolically obese normal-weight (MONW) phenotype has been considered a risk factor for different chronic dis-eases, but its role in high blood pressure (HBP) is still unclear. The aim of the study is to determine if the MONW phenotype constitutes a risk factor for hypertension in Peruvian adults belonging to a 5-year cohort. Methods: This is a retrospective cohort study. A secondary analysis from the database of the PERU MIGRANT study was carried out from the MONW and non-MONW cohorts; after a 5-year follow-up, the appearance of HBP was evaluated in the subjects of both cohorts. To assess the strength and magnitude of the association, a Poisson regression model (crude and adjusted) with robust variance was used. The measure of association was the relative risk (RR). Results: The incidence of HBP was 11.30%. In the multivariable analysis, subjects with the MONW phenotype had a 2.879-fold risk of presenting HBP in 5 years compared with those who were not MONW at the beginning of the study; this was adjusted for catego-rized age, sex, group, and state of smoker and alcohol drinker (RR: 2.055; 95% confidence interval (CI): 1.118-3.777; P = 0.020). Conclusions: The presence of the MONW phenotype doubled the incidence of HBP, even after adjusting for other covariates. How-ever, studies in this field should continue. If these findings are con- firmed, it should be considered that presenting an adequate weight for height should not be interpreted as a condition free of metabolic alterations, so screening for hypertension should be carried out re-gardless of whether or not the body mass index obtained is considered normal.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElmer Press
dc.relation.ispartofurn:issn:1923-2861
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectObesity, Metabolic Health, and Quality of Lifeen_US
dc.subjectMetabolically Healthy Obesity and Associated Risksen_US
dc.titleMetabolically Obese Normal-Weight Phenotype as a Risk Factor for High Blood Pressure: A Five-Year Cohorten_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.14740/jem.v13i1.855
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.18
dc.type.otherResearch article
dc.identifier.journalJournal of Endocrinology and Metabolism
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2